HU9402343D0 - Piperazine and piperadine derivatives, and their use as antipsychoticks - Google Patents

Piperazine and piperadine derivatives, and their use as antipsychoticks

Info

Publication number
HU9402343D0
HU9402343D0 HU9402343A HU9402343A HU9402343D0 HU 9402343 D0 HU9402343 D0 HU 9402343D0 HU 9402343 A HU9402343 A HU 9402343A HU 9402343 A HU9402343 A HU 9402343A HU 9402343 D0 HU9402343 D0 HU 9402343D0
Authority
HU
Hungary
Prior art keywords
antipsychoticks
piperazine
piperadine
derivatives
piperadine derivatives
Prior art date
Application number
HU9402343A
Other languages
Hungarian (hu)
Other versions
HUT72309A (en
Inventor
Mark Henry Norman
Iii Frank Navas
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HU9402343D0 publication Critical patent/HU9402343D0/en
Publication of HUT72309A publication Critical patent/HUT72309A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
HU9402343A 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, having antipsychotic activity pharmaceutical compositions containing them and process for their preparation HUT72309A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202915A GB9202915D0 (en) 1992-02-12 1992-02-12 Chemical compounds

Publications (2)

Publication Number Publication Date
HU9402343D0 true HU9402343D0 (en) 1994-10-28
HUT72309A HUT72309A (en) 1996-04-29

Family

ID=10710223

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402343A HUT72309A (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, having antipsychotic activity pharmaceutical compositions containing them and process for their preparation

Country Status (16)

Country Link
EP (1) EP0625978A1 (en)
JP (1) JPH07503723A (en)
KR (1) KR950700290A (en)
AU (1) AU3460393A (en)
CA (1) CA2117434A1 (en)
CZ (1) CZ194994A3 (en)
FI (1) FI943718A0 (en)
GB (1) GB9202915D0 (en)
HU (1) HUT72309A (en)
IL (1) IL104690A0 (en)
MX (1) MX9300786A (en)
NO (1) NO942977L (en)
RU (1) RU94038064A (en)
SK (1) SK96494A3 (en)
WO (1) WO1993016073A1 (en)
ZA (1) ZA93958B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
RU2118322C1 (en) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-dihydro-1,4-benzodioxine-5-yl-pyrerazine derivatives and salts thereof
AU690622B2 (en) * 1993-12-24 1998-04-30 Daiichi Suntory Pharma Co., Ltd Benzothiazine derivative
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
US6001827A (en) * 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
JPH0912562A (en) * 1995-06-22 1997-01-14 Suntory Ltd Substituted benzothiazine derivative
JP3948744B2 (en) * 1994-11-04 2007-07-25 大日本住友製薬株式会社 Novel lactam derivatives
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
US6087364A (en) * 1998-01-29 2000-07-11 Warner-Lambert Company Dopamine D4 receptor antagonists
DE19814084B4 (en) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
EP1165083A2 (en) * 1999-04-06 2002-01-02 Sepracor Inc. Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
AR028685A1 (en) 2000-06-14 2003-05-21 Lundbeck & Co As H INDOL DERIVATIVES
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (en) 2002-07-30 2007-08-16 Schwarz Pharma Ag Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
EP2295061A1 (en) 2002-08-22 2011-03-16 Dainippon Sumitomo Pharma Co., Ltd. Agent for treatment of schizophrenia
DE10261696A1 (en) 2002-12-30 2004-07-15 Schwarz Pharma Ag Device for the transdermal administration of rotigotine base
JP4624261B2 (en) 2003-06-23 2011-02-02 大日本住友製薬株式会社 Treatment for senile dementia
DE10334188B4 (en) 2003-07-26 2007-07-05 Schwarz Pharma Ag Use of rotigotine to treat depression
WO2005080976A1 (en) 2004-02-20 2005-09-01 Dainippon Sumitomo Pharma Co., Ltd. Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
JP2010514837A (en) * 2007-01-03 2010-05-06 コーテックス ファーマシューティカルズ, インコーポレイテッド 3-Substituted- [1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
WO2013014665A1 (en) * 2011-07-28 2013-01-31 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
BR112016001645B1 (en) * 2013-07-31 2023-04-11 Merck Patent Gmbh OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES, THEIR USE, MEDICINES
CN105669665A (en) * 2016-03-15 2016-06-15 烟台贝森医药科技有限公司 Preparation method of perospirone
WO2018035046A1 (en) 2016-08-15 2018-02-22 President And Fellows Of Harvard College Treating infections using idsd from proteus mirabilis
CN115124464B (en) * 2022-07-04 2023-06-06 新乡学院 Quinoline diketone sulfonyl piperazine hybrid, and preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258843B1 (en) * 1974-01-30 1977-09-09 Roussel Uclaf
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
JPH0625181B2 (en) * 1985-03-27 1994-04-06 住友製薬株式会社 New imide derivative
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
JP2800953B2 (en) * 1990-07-06 1998-09-21 住友製薬株式会社 New imide derivatives

Also Published As

Publication number Publication date
MX9300786A (en) 1994-03-31
FI943718A (en) 1994-08-11
EP0625978A1 (en) 1994-11-30
ZA93958B (en) 1994-08-11
CA2117434A1 (en) 1993-08-19
RU94038064A (en) 1997-05-27
NO942977L (en) 1994-10-10
AU3460393A (en) 1993-09-03
FI943718A0 (en) 1994-08-11
CZ194994A3 (en) 1995-09-13
GB9202915D0 (en) 1992-03-25
HUT72309A (en) 1996-04-29
WO1993016073A1 (en) 1993-08-19
KR950700290A (en) 1995-01-16
JPH07503723A (en) 1995-04-20
SK96494A3 (en) 1995-07-11
IL104690A0 (en) 1993-06-10
NO942977D0 (en) 1994-08-11

Similar Documents

Publication Publication Date Title
HU9402343D0 (en) Piperazine and piperadine derivatives, and their use as antipsychoticks
GB9321855D0 (en) 1,4-piperazine derivatives
SG46281A1 (en) Piperazine derivatives
PH31162A (en) Piperazine derivatives and salts thereof.
ZA927172B (en) Heterocyclic compounds and their preparation and use.
IL122981A0 (en) Piperazine derivatives and their use as 5-HT1A antagonists
GB2277517B (en) Piperazine derivatives
HUP9902668A3 (en) Piperazine derivatives, pharmaceutical compositions containing them and their use
ZA952410B (en) Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals
AU658656B2 (en) 4-phenylmethylpiperazine derivatives and their use as antiallergic and antihistaminic agents
GB9509474D0 (en) Piperazine derivatives
HU9601245D0 (en) N-substituted azabicycloalkane derivatives, their preparation and use
HU9201804D0 (en) Gingerole and gingerdiole derivatives for decreasing cholesterole, with anti-arterosclerosys effect
GB2257430B (en) Piperazine derivatives
GB9321688D0 (en) Piperazine derivatives
ZA915906B (en) 4-aminio-delta 4,6-steroids and their use as 5alpha-reductase inhibitors
GB2286392B (en) Piperazine derivatives and pharmaceutical uses thereof
GB9206062D0 (en) Heterocyclic compounds,their preparation and pharmaceutical use
HU9600660D0 (en) Butenol-triazolyl derivatives, their manufacture and use as microbicides
GB9322017D0 (en) 1,4-piperazine derivatives
ZA924666B (en) Heterocyclic compounds, their production and use
ZA93143B (en) Piperazinyl derivatives
HU9301162D0 (en) New piperazine derivatives
GB9324479D0 (en) Piperazine derivatives
GB9308717D0 (en) Piperazine derivatives

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee